AstraZeneca’s lung cancer treatment seen as breakthrough immunotherapy
Positive late stage trail results for ImfinziFirst and only immunotherapy to demonstrate survival benefitImfinzi is Astra?s second biggest selling cancer drugPharmaceutical giant AstraZeneca (AZN) said a late-stage trial for its...
05 April 2024